Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Cutaneous Lymphoma or Not? Clinicopathologic Challenges and Practical Pearls
Description
Julia Dye from the MD Anderson Cancer Institute discusses the clinicopathologic challenges in diagnosing cutaneous lymphomas. She presents two complex cases to illustrate the diagnostic dilemmas inherent in evaluating these conditions. The first case involves a 20-year-old female presenting with various skin lesions, which were found to be consistent with granulomatous and folliculotropic mycosis fungoides (MF). This case emphasizes the importance of thorough skin examinations and considering cutaneous T-cell lymphoma (CTCL) in differential diagnoses due to the heterogeneous manifestations of the disease. Dye discusses how histopathological examinations and additional immunohistochemical testing can clarify the nature of skin lesions.
The second case involves an 80-year-old man with chronic lymphocytic leukemia and new skin tumors, raising questions about tumor progression or disease transformation. A detailed immunohistochemical and genetic investigation revealed a T follicular helper phenotype driving his T-cell lymphoma. This case exemplifies the necessity of integrating clinical, pathological, and molecular data for accurate diagnosis. Throughout her presentation, Dye stresses the significance of collaboration with dermatopathologists and the value of newer genomic sequencing techniques in understanding and treating complex cutaneous lymphomas. The discussion aims to provide practical insights for managing challenging cases in clinical practice.
Conclusions
- Cutaneous T-cell lymphoma (CTCL) can present with diverse clinical morphologies, necessitating thorough evaluations for diagnoses.
- Multiple clinical phenotypes may exist within a single patient with CTCL, emphasizing the need for comprehensive assessments.
- Biopsying multiple lesion types can aid in the accurate diagnosis and characterization of the disease.
- Immunohistochemistry and T-cell receptor clonality play crucial roles in differentiating CTCL from other granulomatous conditions.
- Granulomatous mycosis fungoides (GMF) is a rare form of CTCL associated with poorer prognosis and requires vigilant management and follow-up.
- High throughput sequencing can reveal shared clones and aid in understanding the malignancy's behavior.
- A multidisciplinary approach involving dermatopathologists and oncologists is essential for optimal patient outcomes in complex cases.
- 1. Kempf W, Ostheeren-Michaelis S, Paulli M, et al. Arch Dermatol. 2008;144(12):1609-1617
- 2. Battesti G, Ram-Wolff C, Dobos G, et al. Br J Dermatol. 2022;187(5):790-793
- 3. Dai J. Granulomatous cutaneous T-cell lymphoma. EORTC. 2024.
- 4. Li JY, Pulitzer MP, Myskowski PL, et al. J Am Acad Dermatol. 2013;69(3):366-374.
- 5. Lenskaya V, Moll EH, Hussein S, et al. Am J Dermatopathol. 2022;44(8): 559-67.
- 6. Pfaltz K, Kerl K, Palmedo G, et al. Am J Dermatopath. 2011;33(7):659-62.
- 7. Park J, Yang J, Wenzel AT, et al. Blood. 2017;130(12):1430-1440.
- 8. Choi J, Goh G, Walradt T, et al. Genomic landscape of cutaneous T cell lymphoma. Nat Genet. 2015;47(9):1011-1019.
- 9. Vaqué JP, Gómez-López G, Monsálvez V, et al. PLCG1 mutations in cutaneous T-cell lymphomas. Blood. 2014;123(13):2034-2043.